| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Division of Molecular Therapeutics, Department of Hematology-Oncology, St. Jude Childrens Research Hospital, Memphis, Tennessee 38105
Signaling pathways involved in survival responses may attenuate the apoptotic response to the cytotoxic tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in human colon carcinomas. In six lines examined, three were sensitive (GC3/c1, VRC5/c1, HCT116), HT29 demonstrated intermediate sensitivity, and RKO and HCT8 were resistant to TRAIL-induced apoptosis. Calphostin c [an inhibitor of classic and novel isoforms of protein kinase C (PKC)] sensitized five of six cell lines to TRAIL, whereas Go6976, (inhibitor of classic PKC isoforms), did not influence TRAIL sensitivity. Rottlerin, an inhibitor of novel isoforms of PKC, specifically PKC
, sensitized five of six cell lines to TRAIL-induced apoptosis, suggesting that PKC
may be involved in the mechanism of TRAIL resistance. Transfection of HCT116 with a proapoptotic cleaved fragment of PKC
or an antiapoptotic full-length PKC
did not influence the sensitivity of HCT116 to TRAIL. Furthermore, the incubation of HCT116 or RKO with phorbol myristate acetate for 16 h, which down-regulated the expression of novel PKC isoforms, also did not influence sensitivity to TRAIL either in the absence or presence of rottlerin. However, after 15-min incubation with rottlerin, mitochondrial membrane potential (
m) was dramatically reduced in RKO cells, and, in cells subsequently treated with TRAIL, rapid apoptosis was evident within 8 h. Calphostin c, but not Go6976, also caused a decrease in 
m. In RKO, rottlerin induced the release of cytochrome c, HtrA2/Omi, Smac/DIABLO, and AIF from the mitochondria, potentiated in combination with TRAIL, with concomitant caspase activation and down-regulation of XIAP. In HT29, the release of proapoptotic factors was demonstrated only when rottlerin and TRAIL were combined, and Bcl-2 overexpression inhibited this release and the induction of apoptosis. TRAIL-induced apoptosis was not influenced by rottlerin or Bcl-2 overexpression in type I (GC3/c1) cells. Data suggest that rottlerin affects mitochondrial function independent of PKC
, thereby sensitizing cells to TRAIL, and that mitochondria constitute an important target in overcoming inherent resistance to TRAIL in colon carcinomas.
This article has been cited by other articles:
![]() |
Y.-H. Kim, Y.-S. Kim, C.-H. Park, I.-Y. Chung, J.-M. Yoo, J.-G. Kim, B.-J. Lee, S.-S. Kang, G.-J. Cho, and W.-S. Choi Protein Kinase C-{delta} Mediates Neuronal Apoptosis in the Retinas of Diabetic Rats via the Akt Signaling Pathway Diabetes, August 1, 2008; 57(8): 2181 - 2190. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Basu, B. Adkins, and C. Basu Down-regulation of Caspase-2 by Rottlerin via Protein Kinase C-{delta}-Independent Pathway Cancer Res., April 15, 2008; 68(8): 2795 - 2802. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Shivshankar, L. Lei, J. Wang, and G. Zhong Rottlerin Inhibits Chlamydial Intracellular Growth and Blocks Chlamydial Acquisition of Sphingolipids from Host Cells Appl. Envir. Microbiol., February 15, 2008; 74(4): 1243 - 1249. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Klinger, J. D. Murray, B. Casserly, D. F. Alvarez, J. A. King, S. S. An, G. Choudhary, A. N. Owusu-Sarfo, R. Warburton, and E. O. Harrington Rottlerin causes pulmonary edema in vivo: a possible role for PKC{delta} J Appl Physiol, December 1, 2007; 103(6): 2084 - 2094. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-Y. Su, Y. Chao, T.-Y. Chen, D.-Y. Huang, and W.-W. Lin 5-Aminoimidazole-4-carboxamide riboside sensitizes TRAIL- and TNF{alpha}-induced cytotoxicity in colon cancer cells through AMP-activated protein kinase signaling Mol. Cancer Ther., May 1, 2007; 6(5): 1562 - 1571. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Phillips, S. Martin, B. T. Doyle, and J. A. Houghton Sphingosine-Induced Apoptosis in Rhabdomyosarcoma Cell Lines Is Dependent on Pre-Mitochondrial Bax Activation and Post-Mitochondrial Caspases Cancer Res., January 15, 2007; 67(2): 756 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Jane, D. R. Premkumar, and I. F. Pollack Coadministration of Sorafenib with Rottlerin Potently Inhibits Cell Proliferation and Migration in Human Malignant Glioma Cells J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1070 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Martin, D. C. Phillips, K. Szekely-Szucs, L. Elghazi, F. Desmots, and J. A. Houghton Cyclooxygenase-2 Inhibition Sensitizes Human Colon Carcinoma Cells to TRAIL-Induced Apoptosis through Clustering of DR5 and Concentrating Death-Inducing Signaling Complex Components into Ceramide-Enriched Caveolae Cancer Res., December 15, 2005; 65(24): 11447 - 11458. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Kim, J. J. Song, J. Y. An, Y. T. Kwon, and Y. J. Lee Pretreatment of Acetylsalicylic Acid Promotes Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis by Down-regulating BCL-2 Gene Expression J. Biol. Chem., December 9, 2005; 280(49): 41047 - 41056. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Gonzalez-Guerrico and M. G. Kazanietz Phorbol Ester-induced Apoptosis in Prostate Cancer Cells via Autocrine Activation of the Extrinsic Apoptotic Cascade: A KEY ROLE FOR PROTEIN KINASE C{delta} J. Biol. Chem., November 25, 2005; 280(47): 38982 - 38991. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Zakharov, J. P. Morrow, G. Liu, L. Yang, and S. O. Marx Activation of the BK (SLO1) Potassium Channel by Mallotoxin J. Biol. Chem., September 2, 2005; 280(35): 30882 - 30887. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Izeradjene, L. Douglas, D. M. Tillman, A. B. Delaney, and J. A. Houghton Reactive Oxygen Species Regulate Caspase Activation in Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Resistant Human Colon Carcinoma Cell Lines Cancer Res., August 15, 2005; 65(16): 7436 - 7445. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Basu, M. Kovarova, A. Garza, S. Kubota, T. Saha, P. S. Mitra, R. Banerjee, J. Rivera, and I. S. Owens Phosphorylation of a UDP-glucuronosyltransferase regulates substrate specificity PNAS, May 3, 2005; 102(18): 6285 - 6290. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Woo, J.-H. Lim, and J.-H. Kim Lipopolysaccharide Induces Matrix Metalloproteinase-9 Expression via a Mitochondrial Reactive Oxygen Species-p38 Kinase-Activator Protein-1 Pathway in Raw 264.7 Cells J. Immunol., December 1, 2004; 173(11): 6973 - 6980. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Izeradjene, L. Douglas, A. Delaney, and J. A. Houghton Influence of Casein Kinase II in Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Human Rhabdomyosarcoma Cells Clin. Cancer Res., October 1, 2004; 10(19): 6650 - 6660. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Deutsch, A. Cohen, G. Kazimirsky, S. Dovrat, H. Rubinfeld, C. Brodie, and R. Sarid Role of Protein Kinase C {delta} in Reactivation of Kaposi's Sarcoma-Associated Herpesvirus J. Virol., September 15, 2004; 78(18): 10187 - 10192. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. I. Geller, K. Szekely-Szucs, I. Petak, B. Doyle, and J. A. Houghton P21Cip1 Is a Critical Mediator of the Cytotoxic Action of Thymidylate Synthase Inhibitors in Colorectal Carcinoma Cells Cancer Res., September 1, 2004; 64(17): 6296 - 6303. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sonnemann, V. Gekeler, A. Sagrauske, C. Muller, H.-P. Hofmann, and J. F. Beck Down-regulation of protein kinase C{eta} potentiates the cytotoxic effects of exogenous tumor necrosis factor-related apoptosis-inducing ligand in PC-3 prostate cancer cells Mol. Cancer Ther., July 1, 2004; 3(7): 773 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. N. Demidenko and M. V. Blagosklonny Flavopiridol Induces p53 via Initial Inhibition of Mdm2 and p21 and, Independently of p53, Sensitizes Apoptosis-Reluctant Cells to Tumor Necrosis Factor Cancer Res., May 15, 2004; 64(10): 3653 - 3660. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |